Breast cancer spheroids enriched with CD44+/CD24- cells grew tumors and targeting these CSCs with niclosamide inhibited spheroid formation, induced apoptosis, and inhibited tumor growth in mice (Fig. 5f) [79]. This evidence concerns the gene CD44 and breast carcinoma.